Calzada Limited (CZD) Company Profile - CorporateInformation.com


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Calzada Limited Company Snapshot

Business Description:

Calzada Limited operates in the Noncommercial research organizations sector. Calzada Limited is an Australia-based biotechnology company. It operates in the pharmaceutical and healthcare industry. The Company is focused on the development of medical devices for medical applications using its NovoSorb technology. NovoSorb is non-toxic and non-immunogenic and produces safe biodegradation products on erosion. During the fiscal year ended June 30, 2011 (fiscal 2011), the Company owned 100% interest in PolyNovo Biomaterials Pty Ltd (PolyNovo) and Metabolic Pharmaceuticals Pty Ltd (Metabolic). PolyNovo is a life science company focused on developing its novel and patented biodegradable polymer platform NovoSorb for medical products focused on medical and surgical outcomes. PolyNovo's projects include Smith & Nephew and NovoSkin Pty Ltd. Metabolic's major asset is the AOD9604 peptide, which has applications in the treatment of obesity and bone disease.

Stock Performance Chart for Calzada Limited

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): .05
(Figures in Australian Dollars)

1 Week	-4.0%	13 Weeks	-15.8%

4 Weeks	-12.7%	52 Weeks	45.5%

Calzada Limited Key Data:

Ticker:	CZD	Country:	AUSTRALIA

Exchanges:	OTC	Major Industry:	Miscellaneous

		Sub Industry:	Medical Services

2001 Sales	(Year Ending Jan 2002).	Employees:	4

Currency:	Australian Dollars	Market Cap:	16,638,349

Fiscal Yr Ends:	June	Shares Outstanding:	346,632,277

Share Type:	Ordinary	Closely Held Shares:	66,412,372

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.